| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | 53.63% | Keybanc | $180 → $130 | Maintains | Overweight |
| 11/02/2023 | — | Barclays | Upgrades | Underweight → Equal-Weight | |
| 10/30/2023 | 29.99% | Morgan Stanley | $154 → $110 | Maintains | Equal-Weight |
| 10/19/2023 | 100.9% | Stifel | $186 → $170 | Maintains | Buy |
| 07/31/2023 | 74.9% | Citigroup | $165 → $148 | Maintains | Neutral |
| 07/27/2023 | 81.99% | Morgan Stanley | $159 → $154 | Maintains | Equal-Weight |
| 07/27/2023 | 112.72% | Keybanc | $200 → $180 | Maintains | Overweight |
| 07/07/2023 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 05/31/2023 | 94.99% | Citigroup | $186 → $165 | Maintains | Neutral |
| 04/27/2023 | 87.9% | Morgan Stanley | $207 → $159 | Maintains | Equal-Weight |
| 04/27/2023 | 112.72% | TD Cowen | $200 → $180 | Maintains | Outperform |
| 04/27/2023 | 136.35% | Keybanc | $210 → $200 | Maintains | Overweight |
| 02/07/2023 | 119.81% | Citigroup | $150 → $186 | Maintains | Neutral |
| 02/02/2023 | 124.53% | Wells Fargo | $155 → $190 | Maintains | Overweight |
| 02/02/2023 | 136.35% | Cowen & Co. | $175 → $200 | Maintains | Outperform |
| 02/02/2023 | 144.62% | Morgan Stanley | $151 → $207 | Maintains | Equal-Weight |
| 02/02/2023 | — | Summit Insights Group | Upgrades | Hold → Buy | |
| 02/02/2023 | 148.17% | Keybanc | $160 → $210 | Maintains | Overweight |
| 01/23/2023 | 18.18% | Barclays | $85 → $100 | Maintains | Underweight |
| 01/09/2023 | 83.17% | Wells Fargo | $145 → $155 | Maintains | Overweight |
| 10/27/2022 | 0.45% | Barclays | $95 → $85 | Maintains | Underweight |
| 10/27/2022 | 78.44% | Morgan Stanley | $161 → $151 | Maintains | Equal-Weight |
| 10/27/2022 | — | Needham | Downgrades | Buy → Hold | |
| 10/27/2022 | 89.08% | Keybanc | $180 → $160 | Maintains | Overweight |
| 10/24/2022 | 12.27% | Barclays | $140 → $95 | Downgrades | Equal-Weight → Underweight |
| 07/28/2022 | 90.26% | Morgan Stanley | $156 → $161 | Maintains | Equal-Weight |
| 07/28/2022 | — | Summit Insights Group | Downgrades | Buy → Hold | |
| 07/28/2022 | 94.99% | Needham | $150 → $165 | Maintains | Buy |
| 07/11/2022 | 100.9% | Wells Fargo | $190 → $170 | Maintains | Overweight |
| 04/28/2022 | 183.62% | Needham | $230 → $240 | Maintains | Buy |
| 04/28/2022 | 112.72% | Keybanc | $210 → $180 | Maintains | Overweight |
| 04/25/2022 | 84.35% | Morgan Stanley | $208 → $156 | Maintains | Equal-Weight |
| 03/07/2022 | 171.8% | Needham | $210 → $230 | Maintains | Buy |
| 12/21/2021 | 165.89% | Wells Fargo | $190 → $225 | Maintains | Overweight |
| 12/15/2021 | 145.8% | Morgan Stanley | $192 → $208 | Maintains | Equal-Weight |
| 11/12/2021 | 165.89% | Stifel | $200 → $225 | Maintains | Buy |
| 10/28/2021 | 126.9% | Morgan Stanley | $153 → $192 | Maintains | Equal-Weight |
| 10/28/2021 | 89.08% | Barclays | $125 → $160 | Maintains | Equal-Weight |
| 10/28/2021 | 148.17% | Needham | $195 → $210 | Maintains | Buy |
| 10/28/2021 | 148.17% | Keybanc | $185 → $210 | Maintains | Overweight |
| 07/29/2021 | 80.81% | Morgan Stanley | $160 → $153 | Maintains | Equal-Weight |
| 05/19/2021 | 59.54% | Citigroup | $163 → $135 | Downgrades | Buy → Neutral |
| 04/29/2021 | 89.08% | Morgan Stanley | $156 → $160 | Maintains | Equal-Weight |
| 04/29/2021 | 83.17% | JP Morgan | → $155 | Downgrades | Overweight → Neutral |
| 04/23/2021 | 118.62% | Keybanc | → $185 | Upgrades | Sector Weight → Overweight |
| 02/24/2021 | 112.72% | Wells Fargo | $165 → $180 | Maintains | Overweight |
| 02/22/2021 | 124.53% | Benchmark | $155 → $190 | Maintains | Buy |
| 02/22/2021 | 84.35% | Morgan Stanley | $143 → $156 | Maintains | Equal-Weight |
| 02/22/2021 | 130.44% | Needham | $150 → $195 | Maintains | Buy |
| 02/04/2021 | 77.26% | Needham | $120 → $150 | Maintains | Buy |
| 02/04/2021 | 65.45% | Loop Capital | $108 → $140 | Maintains | Hold |
| 02/04/2021 | 77.26% | Roth Capital | $140 → $150 | Maintains | Buy |
| 01/19/2021 | 68.99% | Morgan Stanley | → $143 | Initiates Coverage On | → Equal-Weight |
| 01/04/2021 | 65.45% | Roth Capital | $120 → $140 | Maintains | Buy |
| 07/30/2020 | 41.81% | Citigroup | $115 → $120 | Maintains | Buy |
| 07/20/2020 | 24.08% | Barclays | $90 → $105 | Maintains | Equal-Weight |
| 04/30/2020 | 39.45% | Benchmark | $100 → $118 | Maintains | Buy |
| 04/17/2020 | 6.36% | Barclays | $95 → $90 | Maintains | Equal-Weight |
| 03/13/2020 | 9.9% | Citigroup | $123 → $93 | Maintains | Buy |
| 03/13/2020 | 18.18% | Needham | $115 → $100 | Maintains | Buy |
| 03/05/2020 | 35.9% | Needham | → $115 | Upgrades | Hold → Buy |
| 01/30/2020 | 45.36% | Citigroup | $130 → $123 | Maintains | Buy |
| 01/29/2020 | — | Summit Insights Group | Downgrades | Buy → Hold | |
| 12/20/2019 | 53.63% | Wells Fargo | $125 → $130 | Maintains | Overweight |
| 07/23/2019 | 41.81% | Benchmark | → $120 | Initiates Coverage On | → Buy |
| 06/25/2019 | 47.72% | Wells Fargo | → $125 | Initiates Coverage On | → Outperform |
| 01/31/2019 | — | Needham | Downgrades | Buy → Hold |
What is the target price for Silicon Laboratories (SLAB)?
The latest price target for Silicon Laboratories (NASDAQ: SLAB) was reported by Keybanc on November 2, 2023. The analyst firm set a price target for $130.00 expecting SLAB to rise to within 12 months (a possible 53.63% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Silicon Laboratories (SLAB)?
The latest analyst rating for Silicon Laboratories (NASDAQ: SLAB) was provided by Keybanc, and Silicon Laboratories maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Silicon Laboratories (SLAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Silicon Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Silicon Laboratories was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating Silicon Laboratories (SLAB) correct?
While ratings are subjective and will change, the latest Silicon Laboratories (SLAB) rating was a maintained with a price target of $180.00 to $130.00. The current price Silicon Laboratories (SLAB) is trading at is $84.62, which is out of the analyst's predicted range.